Pharma
Filter By: News | Articles | Products | Posters | White Papers | Videos | Podcasts | Application Notes | Journal Articles
Merck KGaA acquires Millipore
Mar 1 | News
Merck KGaA and Millipore Corporation announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately € 5.3 billion (US$ 7.2 billion).
Slowing Evolution to Stop Drug Resistance
Nov 19 2009 | News
Infectious organisms that become resistant to antibiotics are a serious threat to human society. They are also a natural part of evolution. In a new project, researchers at the University of Gothenburg are attempting to find substances that can slow the pace of evolution, in order to ensure that the drugs of today remain effective into the future.
Fine Tuning Treatments for Depression
Oct 19 2009 | News
New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated – a finding that may help fine-tune therapies for depression.
A Flash of Inspiration
Oct 13 2009 | Bioscience Technology Blog
According to IBM, DNA origami causes single DNA molecules to self assemble in solution via a reaction between a long single strand of viral DNA and a mixture of different short synthetic oligonucleotide strands.
They Like Me, They Like Me Not
Oct 13 2009 | Bioscience Technology Blog
It should come as no surprise to you all that your profession—science—is highly respected by the general public. I’m sure many of you expected this, but now there is validation in the form of a survey conducted by The Pew Research Center for the People and the Press.
Why We Do What We Do
Oct 13 2009 | Bioscience Technology Blog
Our industry is unique in that it is often only limited by the imagination of those working in it. If you can think of it and find funding (which often presents its own difficulties), then you can work on it.
Biochemists Prolong the Half-life of Pharmacological Substances
Sep 22 2009 | News
Many biopharmaceuticals comprise small proteins that are quickly eliminated from the body. Scientists at the Technische Universitaet Muenchen (TUM) combine such small proteins with a kind of molecular balloon that swells and thus prolongs the half-life of the proteins in the body.
RNAi Found in Budding Yeasts
Sep 15 2009 | News
RNAi, a key biochemical pathway in the genetic control networks of most organisms, has now been discovered in Saccharomyces castellii, a close relative of the prototypical budding yeast S. cerevisiae, and in Candida albicans, a common human pathogen.